Editorial: Modification of the innate immune function of dendritic cells by allergen-specific immunotherapy

Clinical and Experimental Allergy

Volumn 40, Issue 1, 2010, Pages 12-14

  Bellinghausen, Iris ^a,b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ALPHA INTERFERON; BEE VENOM; CPG OLIGODEOXYNUCLEOTIDE; EPITOPE; IMMUNOGLOBULIN G4; INTERLEUKIN 6; PATTERN RECOGNITION RECEPTOR; RAGWEED ANTIGEN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; VACCINE; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; OLIGODEOXYRIBONUCLEOTIDE;

ALLERGEN SPECIFIC IMMUNOTHERAPY; ALLERGY; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; EDITORIAL; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; IMMUNOTHERAPY; INNATE IMMUNITY; NONHUMAN; POLLEN ALLERGY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; THERAPY EFFECT; ADAPTIVE IMMUNITY; ANIMAL; DESENSITIZATION; HYPERSENSITIVITY; IMMUNOLOGY; METHODOLOGY; NOTE;

ADAPTIVE IMMUNITY; ALLERGENS; ANIMALS; DENDRITIC CELLS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; OLIGODEOXYRIBONUCLEOTIDES; TOLL-LIKE RECEPTOR 9;

EID: 72949102205     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2009.03415.x     Document Type: Editorial

References (21)

1. Cox L. Allergen immunotherapy and asthma: efficacy, safety, and other considerations. Allergy Asthma Proc 2008 29 : 580 589.
2. Hafner T, DuBuske L, Kosnik M. Long-term efficacy of venom immunotherapy. Ann Allergy Asthma Immunol 2008 100 : 162 165.
3. Larche M, Akdis CA, Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006 6 : 761 771.
4. Akdis M. Immune tolerance in allergy. Curr Opin Immunol 2009 21 : 1 8.
5. Bellinghausen I, Konig B, Bottcher I, Knop J, Saloga J. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction. Clin Exp Allergy 2006 36 : 1546 1555.
6. Rolland JM, Gardner LM, O'Hehir RE. Allergen-related approaches to immunotherapy. Pharmacol Ther 2009 121 : 273 284.
7. Fonseca DE, Kline JN. Use of CpG oligonucleotides in treatment of asthma and allergic disease. Adv Drug Deliv Rev 2009 61 : 256 262.
8. Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006 311 : 17 58.
9. Tversky JR, Bieneman AP, Chichester KL, Hamilton RG, Schroeder JT. Subcutaneous allergen immunotherapy restores human dendritic cell innate immune function. Clin Exp Allergy 2009 40 : 94 102.
10. Tversky JR, Le TV, Bieneman AP, Chichester KL, Hamilton RG, Schroeder JT. Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9. Clin Exp Allergy 2008 38 : 781 788.
11. Gehlhar K, Bilitewski C, Reinitz-Rademacher K, Rohde G, Bufe A. Impaired virus-induced interferon-alpha2 release in adult asthmatic patients. Clin Exp Allergy 2006 36 : 331 337.
12. Schroeder JT, Chichester KL, Bieneman AP. Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-alpha. J Allergy Clin Immunol 2008 121 : 486 491.
13. Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006 6 : 644 658.
14. Shinohara ML, Lu L, Bu J et al. Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat Immunol 2006 7 : 498 506.
15. Tian J, Avalos AM, Mao SY et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007 8 : 487 496.
16. Konno S, Golden DB, Schroeder J, Hamilton RG, Lichtenstein LM, Huang SK. Level of osteopontin is increased after bee venom immunotherapy. J Allergy Clin Immunol 2005 115 : 1317 1318.
17. Moseman EA, Liang X, Dawson AJ et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol 2004 173 : 4433 4442.
18. Creticos PS, Schroeder JT, Hamilton RG et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 2006 355 : 1445 1455.
19. Patel P, Salapatek AM. Pollinex Quattro: a novel and well-tolerated, ultra short-course allergy vaccine. Expert Rev Vaccines 2006 5 : 617 629.
20. Gerstmayr M, Ilk N, Schabussova I et al. A novel approach to specific allergy treatment: the recombinant allergen-S-layer fusion protein rSbsC-Bet v 1 matures dendritic cells that prime Th0/Th1 and IL-10-producing regulatory T cells. J Immunol 2007 179 : 7270 7275.
21. Lambrecht BN, Hammad H. Biology of lung dendritic cells at the origin of asthma. Immunity 2009 31 : 412 424.